- Exchange: Toronto
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Cynapsus Therapeutics Inc+ Add to Watchlist
CTH:CN1.2500 CAD 0.0400 3.31%
As of 15:59:54 ET on 04/24/2015.
Company Profile for Cynapsus Therapeutics Inc (CTH)
Cynapsus Therapeutics, Inc. researches and develops pharmaceuticals. The Company researches treatments for Parkinson's disease, neuropathic pain associated with multiple sclerosis and cancer, and nausea and vomiting and appetite stimulation.
Cynapsus Therapeutics Inc
Key Executives for Cynapsus Therapeutics Inc (CTH)
|Anthony J GiovinazzoPresident/CEO||Andrew Michael WilliamsCFO/COO/Secretary|
|Albert AgroChief Medical Ofcr/Co-Founder||Thierry BilbaultExec VP:CMC/Chief Scientific Ofcr|
|Jordan DubowVP:Medical Affairs|